ben.kiefel
Client
Joined May 2021
ContestContests
Logos
Status
Prize *
HULA Therapeutics
Biotech developing highly targeted cancer treatments for children (Paediatric Oncology).
Our name is derived from the molecule we can (uniquely) target, the Human Leukocyte Antigen.
Our target audience is VC investors, Big Pharma and, eventually, stock purchasing investors.
219
Logos
Complete
Status
$275
Prize
HULA Therapeutics
Biotech developing highly targeted cancer treatments for children (Paediatric Oncology).
Our name is derived from the molecule we can (uniquely) target, the Human Leukocyte Antigen.
Our target audience is VC investors, Big Pharma and, eventually, stock purchasing investors.
219
Complete
$275
* The Prize Package includes the Designer prize and all LogoTournament fees.